Alastin Skincare has announced its third formulation patent, issued by the United States Patent and Trademark Office, for its TransFORM Body Treatment with TriHex Technology.
The product is also The Beauty Authority's New Beauty 2019 winner.
The U.S. Patent No. 10,493,011 is entitled, "Peptide Compositions and Methods for Ameliorating Skin Laxity and Body Contour."
This patent is directed to the composition and uses related to Alastin's TransFORM Body Treatment, when used alone as well as when used in conjunction with body-shaping procedures.
The unique product technology is reinforced by peer-reviewed published papers and clinical studies that support the efficacy of the product line.
According to Dr. Laurie Casas, Clinical Professor of Surgery at the University of Chicago Medical Center and owner of Casas Aesthetic Plastic Surgery, "With TransFORM Body Treatment, I am finally able to provide patients with a topical product that perfectly complements invasive and non-invasive fat reduction and body contouring procedures and energy-based body sculpting procedures by accelerating results as well as improving skin tone and crepiness, ensuring patient's receive ideal post treatment outcomes."
Diane S. Goostree, CEO of Alastin Skincare, adds, "As we expand the Alastin portfolio, our patented TriHex Technology formulations continue to be the building blocks of our ongoing success. We are proud to be leading the U.S. aesthetic market and to enhancing the outcomes desired by our physician customers and their patients."